OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effects of elafibranor on liver fibrosis and gut barrier function in a mouse model of alcohol-associated liver disease
Aritoshi Koizumi, Kosuke Kaji, Norihisa Nishimura, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 28, pp. 3428-3446
Open Access | Times Cited: 13
Aritoshi Koizumi, Kosuke Kaji, Norihisa Nishimura, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 28, pp. 3428-3446
Open Access | Times Cited: 13
Showing 13 citing articles:
Peroxisome proliferator–activated receptor delta and liver diseases
Tomoo Yamazaki, Edward E. Cable, Bernd Schnabl
Hepatology Communications (2025) Vol. 9, Iss. 2
Open Access
Tomoo Yamazaki, Edward E. Cable, Bernd Schnabl
Hepatology Communications (2025) Vol. 9, Iss. 2
Open Access
Therapeutic potential of elafibranor in alcohol-associated liver disease: Insights into macrophage modulation and fibrosis reduction
Samira Farhadi, Saeed Mohammadi, Abdulaziz Alkindi, et al.
World Journal of Biological Chemistry (2025) Vol. 16, Iss. 1
Open Access
Samira Farhadi, Saeed Mohammadi, Abdulaziz Alkindi, et al.
World Journal of Biological Chemistry (2025) Vol. 16, Iss. 1
Open Access
Elafibranor: A promising treatment for alcoholic liver disease, metabolic-associated fatty liver disease, and cholestatic liver disease
Hang Zhang, Xuan Dong, Lei Zhu, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 40, pp. 4393-4398
Closed Access | Times Cited: 2
Hang Zhang, Xuan Dong, Lei Zhu, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 40, pp. 4393-4398
Closed Access | Times Cited: 2
Elafibranor alleviates alcohol-related liver fibrosis by restoring intestinal barrier function
Yuqi Sun, Yang Wu, Mengran Li, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 43, pp. 4660-4668
Closed Access | Times Cited: 2
Yuqi Sun, Yang Wu, Mengran Li, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 43, pp. 4660-4668
Closed Access | Times Cited: 2
Dual peroxisome proliferator-activated receptor α/δ agonists: Hope for the treatment of alcohol-associated liver disease?
Xinyang Zhang, Qin-Jun-Jie Chen, Feng Zhu, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 37, pp. 4163-4167
Closed Access | Times Cited: 1
Xinyang Zhang, Qin-Jun-Jie Chen, Feng Zhu, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 37, pp. 4163-4167
Closed Access | Times Cited: 1
Elafibranor: A promising treatment for alcohol-associated liver disease?
Hong Wei, Li-Xuan Sang, Bing Chang
World Journal of Gastroenterology (2024) Vol. 30, Iss. 39, pp. 4313-4317
Closed Access | Times Cited: 1
Hong Wei, Li-Xuan Sang, Bing Chang
World Journal of Gastroenterology (2024) Vol. 30, Iss. 39, pp. 4313-4317
Closed Access | Times Cited: 1
Prospects of elafibranor in treating alcohol-associated liver diseases
Wanzhen Cui, Huadan Xue, Daimin Wei, et al.
World Journal of Gastroenterology (2024) Vol. 31, Iss. 2
Closed Access
Wanzhen Cui, Huadan Xue, Daimin Wei, et al.
World Journal of Gastroenterology (2024) Vol. 31, Iss. 2
Closed Access
Elafibranor: A promising therapeutic approach for liver fibrosis and gut barrier dysfunction in alcohol-associated liver disease
Chun‐Han Cheng, Wen‐Rui Hao, Tzu-Hurng Cheng
World Journal of Gastroenterology (2024) Vol. 31, Iss. 3
Closed Access
Chun‐Han Cheng, Wen‐Rui Hao, Tzu-Hurng Cheng
World Journal of Gastroenterology (2024) Vol. 31, Iss. 3
Closed Access
Peroxisome proliferator-activated receptor agonists: A new hope towards the management of alcoholic liver disease
Siva Sundara Kumar Durairajan, Abhay Singh, Ashok Iyaswamy
World Journal of Gastroenterology (2024) Vol. 30, Iss. 35, pp. 3965-3971
Closed Access
Siva Sundara Kumar Durairajan, Abhay Singh, Ashok Iyaswamy
World Journal of Gastroenterology (2024) Vol. 30, Iss. 35, pp. 3965-3971
Closed Access
Signaling pathways that activate hepatic stellate cells during liver fibrosis
Youtian Zhang, Long Ren, Yinting Tian, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Youtian Zhang, Long Ren, Yinting Tian, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Novel intervention for alcohol-associated liver disease
Fei-Qiong Gao, Jiaqi Zhu, Xudong Feng
World Journal of Gastroenterology (2024) Vol. 30, Iss. 39, pp. 4308-4312
Closed Access
Fei-Qiong Gao, Jiaqi Zhu, Xudong Feng
World Journal of Gastroenterology (2024) Vol. 30, Iss. 39, pp. 4308-4312
Closed Access
Bile acids supplementation improves colonic mucosal barrier via alteration of bile acids metabolism and gut microbiota composition in goats with subacute ruminal acidosis (SARA)
Manman Hou, Pin Song, Yue Chen, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 287, pp. 117313-117313
Open Access
Manman Hou, Pin Song, Yue Chen, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 287, pp. 117313-117313
Open Access
Elafibranor, a dual PPARα and PPARδ agonist, reduces alcohol-associated liver disease: Lessons from a mouse model
Luciano Pirola
World Journal of Gastroenterology (2024) Vol. 31, Iss. 4
Closed Access
Luciano Pirola
World Journal of Gastroenterology (2024) Vol. 31, Iss. 4
Closed Access
